作者: Anat Elmann , Yoel Kashman , Rivka Ofir
DOI:
关键词:
摘要: The invention relates to 3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone (T I F) and achillolid A in prevention or treatment of Alzheimer's disease as well other neurodegenerative diseases such Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), ischemia, immunodeficiency virus-1 (HTV-l)-associated dementia, Lewy body associated traumatic brain injury (TBI), glioma, epilepsy, Huntington's multiple sclerosis, glaucoma schizophrenia where neuroinflammation, oxidative stress, glutamate toxicity amyloid beta are part the pathophysiology.